semaglutide and eye blindness condition A new study suggests patients taking — the active ingredient in Ozempic Wegovy — may be at higher risk of developing an that can cause blindness. Non-arteritic anterior Ozempic Vision Loss: What Patients

2025;14(12):e2403603

2 Cumulative event rate of (A) proliferative diabetic retinopathy and (B) composite surgical outcome in patients with type 2 diabetes mellitus taking sodium-glucose cotransporter-2 inhibitor (SGLT2i) versus glucagon-like peptide-1 receptor agonist (GLP1-RA) in the inverse probability of treatment weighting-adjusted cohort

In the separate case of Whittemore v

GLP-1 inhibitors might be a suitable option if: You've struggled to manage your weight despite healthy lifestyle habits

NO regulatory agency has evaluated oral tirzepatide

However, limited evidence suggests they are effective for the management of ASD-related mood changes and behaviors